ZDHHC9
Palmitoyltransferase ZDHHC9
Also known as: CGI-89, CXorf11, DHHC9, ZDHC9_HUMAN, ZDHHC10, ZNF379, ZNF380
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y397
- Gene
- ZDHHC9
- Ensembl
- ENSG00000188706
- Chromosome
- X
- Canonical length
- 364 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes an integral membrane protein that is a member of the zinc finger DHHC domain-containing protein family. The encoded protein forms a complex with golgin subfamily A member 7 and functions as a palmitoyltransferase. This protein specifically palmitoylates HRAS and NRAS. Mutations in this gene are associated with X-linked cognitive disability. Alternate splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q9Y397|ZDHHC9
1 MSVMVVRKKV TRKWEKLPGR NTFCCDGRVM MARQKGIFYL TLFLILGTCT LFFAFECRYL
61 AVQLSPAIPV FAAMLFLFSM ATLLRTSFSD PGVIPRALPD EAAFIEMEIE ATNGAVPQGQ
121 RPPPRIKNFQ INNQIVKLKY CYTCKIFRPP RASHCSICDN CVERFDHHCP WVGNCVGKRN
181 YRYFYLFILS LSLLTIYVFA FNIVYVALKS LKIGFLETLK ETPGTVLEVL ICFFTLWSVV
241 GLTGFHTFLV ALNQTTNEDI KGSWTGKNRV QNPYSHGNIV KNCCEVLCGP LPPSVLDRRG
301 ILPLEESGSR PPSTQETSSS LLPQSPAPTE HLNSNEMPED SSTPEEMPPP EPPEPPQEAA
361 EAEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZDHHC9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 53 nTPM
- cerebral cortex: 39 nTPM
- liver: 38 nTPM
- hippocampal formation: 37 nTPM
- kidney: 35 nTPM
- skin: 33 nTPM
Single-cell type
- pituicytes/fscs: 224 nCPM
- alveolar cells type 1: 217 nCPM
- oligodendrocytes: 173 nCPM
- alveolar cells type 2: 156 nCPM
- transitional alveolar cells: 130 nCPM
- endometrial luminal cells: 106 nCPM
Immune cell
- non-classical monocyte: 5.2 nTPM
- plasmacytoid DC: 5.2 nTPM
- naive CD4 T-cell: 4.5 nTPM
- MAIT T-cell: 3.7 nTPM
- memory CD4 T-cell: 3.6 nTPM
- gdT-cell: 3 nTPM
Brain region
- white matter: 137 nTPM
- basal ganglia: 116 nTPM
- cerebral cortex: 106 nTPM
- medulla oblongata: 106 nTPM
- midbrain: 100 nTPM
- thalamus: 99 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZDHHC9.
Disease | AllUniProt
Conditions ZDHHC9 is implicated in, by any mechanism.
- Intellectual developmental disorder, X-linked, syndromic, Raymond type (MRXSR) MIM:300799
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 377 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Syndromic X-linked intellectual disability Raymond type
- Inborn genetic diseases
- Intellectual disability
- Thyroid cancer, nonmedullary, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.74
- gnomAD missense Z
- 2.55
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- host-mediated activation of viral process
- MAPK cascade
- non-canonical inflammasome complex assembly
- peptidyl-L-cysteine S-palmitoylation
- positive regulation of cGAS/STING signaling pathway
- positive regulation of pyroptotic inflammatory response
- post-translational protein modification
- protein maturation
- protein targeting to membrane
Molecular functions
- palmitoyltransferase activity
- protein-cysteine S-palmitoyltransferase activity
- Ras palmitoyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZDHHC9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZDHHC9 as an antibody target. Whether an autoantibody or antibody against ZDHHC9 could matter depends on whether native ZDHHC9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZDHHC9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZDHHC9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...